Gene symbol | MS4A1 | Synonyms | B1, Bp35, CD20, CVID5, FMC7, LEU-16, S7 | Type of gene | protein-coding | |
Chromosome | 11 | Map location | 11q12.2 | dbXrefs | Entrez:931 MIM:112210 HGNC:HGNC:7315 Ensembl:ENSG00000156738 AllianceGenome:HGNC:7315 | |
Description | membrane spanning 4-domains A1 |
GTO ID | GTC1780 |
Trial ID | NCT03277729 |
Disease | B-Cell Non-Hodgkin's Lymphoma |
Altered gene | CD20 |
Therapeutic/Target gene | Target gene |
Therapy | CAR-T cell |
Treatment | CD20 CAR-T cells |
Phase | Phase1|Phase2 |
Recruitment status | Recruiting |
Title | A Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas |
Year | 2017 |
Country | United States |
Company sponsor | Fred Hutchinson Cancer Center |
Other ID(s) | 9738|NCI-2017-01595|9738|RG9217017 |
Cohort 1 | |||||||||||
|